Clinical Annotation for CYP2C9*1, CYP2C9*2, CYP2C9*3, warfarin, Cardiovascular Diseases and Heart Diseases (level 1A Dosage)

Level of Evidence
Level 1A
Type
Dosage
Variant
*1, *2, *3
Genes
CYP2C9
Phenotypes
Cardiovascular Diseases, Heart Diseases
OMB Race
Mixed Population

To see the rest of this clinical annotation please register or sign in.

Clinical Annotation History